<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR44">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Saijo</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Morikawa</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Fukushi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mizutani</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Hasegawa</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Nagata</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Iwata</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Kurane</surname>
    <given-names>I</given-names>
   </name>
  </person-group>
  <article-title>Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus</article-title>
  <source>Antivir Res</source>
  <year>2005</year>
  <volume>66</volume>
  <issue>2â€“3</issue>
  <fpage>159</fpage>
  <lpage>163</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2005.01.003</pub-id>
  <pub-id pub-id-type="pmid">15911031</pub-id>
 </element-citation>
</ref>
